Adalimumab/infliximabAcute infusion reaction and lack of efficacy

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 1991卷 / 1期

关键词：

D O I：

10.1007/s40278-024-52528-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：16 / 16

相关论文

共 50 条

[31] Adalimumab/azathioprine/ceftriaxoneLegionellosis and lack of efficacy: case report
Reactions Weekly, 2023, 1963 (1) : 23 - 23
[32] Adalimumab/methotrexateChilblain lupus and lack of efficacy: case report
Reactions Weekly, 2020, 1823 (1) : 24 - 24
[33] Adalimumab/minocyclineCutaneous leishmaniasis and lack of efficacy: case report
Reactions Weekly, 2022, 1896 (1) : 23 - 23
[34] Adalimumab/mesalazineParadoxical psoriasis and lack of efficacy: case report
Reactions Weekly, 2025, 2050 (1) : 23 - 23
[35] Adalimumab/rifampicinLeukocytoclastic vasculitis and lack of efficacy: case report
Reactions Weekly, 2021, 1873 (1) : 20 - 20
[36] Adalimumab/methotrexateCytomegalovirus oesophagitis and lack of efficacy: case report
Reactions Weekly, 2023, 1969 (1) : 24 - 24
[37] Adalimumab/infliximabThrombocytopenia and infusion reaction: 2 case reports
Reactions Weekly, 2022, 1914 (1) : 22 - 22
[38] Adalimumab/mycophenolate/prednisoloneAllergic reaction, lack of efficacy and rebound effect in the form of scleritis flare-up
Reactions Weekly, 2024, 2008 (1) : 22 - 22
[39] InfliximabAcute severe infusion reactions: 4 case reports
Reactions Weekly, 2011, 1368 (1) : 22 - 22
[40] Adalimumab/infliximabVarious toxicities and lack of efficacy: 6 case reports
Reactions Weekly, 2021, 1859 (1) : 15 - 15

← 1 2 3 4 5 →